Organon Correlations

OGN Stock  USD 15.79  0.09  0.57%   
The current 90-days correlation between Organon and Biogen Inc is 0.48 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon Co moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Organon Correlation With Market

Modest diversification

The correlation between Organon Co and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Organon Co and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Moving against Organon Stock

  0.42DRUG Bright Minds BiosciencesPairCorr
  0.33VERA Vera TherapeuticsPairCorr
  0.37ENTO Entero Therapeutics, Symbol ChangePairCorr
  0.35CDTTW Conduit PharmaceuticalsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AMGNJNJ
GILDJNJ
AZNJNJ
AZNAMGN
ABBVJNJ
GILDABBV
  
High negative correlations   
MRKLLY
AZNMRK
MRKAMGN
MRKJNJ
MRKABBV
SNYMRK

Risk-Adjusted Indicators

There is a big difference between Organon Stock performing well and Organon Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Organon's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
JNJ  0.89  0.16  0.22  1.67  0.95 
 1.79 
 5.95 
BMY  1.23  0.07  0.08  1.96  1.84 
 3.18 
 7.43 
ABBV  1.05  0.32  0.41  2.68  0.69 
 2.37 
 6.46 
LLY  1.49  0.11  0.07  0.10  2.11 
 2.45 
 10.31 
PFE  1.05  0.08  0.13  0.42  1.17 
 2.20 
 7.11 
AMGN  1.05  0.28  0.21  0.44  1.25 
 2.22 
 9.76 
MRK  1.17 (0.07) 0.00  1.31  0.00 
 2.07 
 11.58 
GILD  1.06  0.32  0.30  0.99  0.93 
 2.28 
 9.83 
SNY  1.16  0.30  0.31 (2.03) 0.96 
 2.77 
 10.59 
AZN  0.94  0.24  0.27  1.20  0.98 
 2.00 
 5.20 

Organon Corporate Management

Susan ONealChief OfficerProfile
Rebecca EdwardsChief OfficerProfile
Rachel StahlerExecutive OfficerProfile
Susanne FiedlerExecutive OfficerProfile
Daniel KarpExecutive DevelopmentProfile